A Cre-dependent massively parallel reporter assay allows for cell-type specific assessment of the functional effects of non-coding elements in vivo

The function of regulatory elements is highly dependent on the cellular context, and thus for understanding the function of elements associated with psychiatric diseases these would ideally be studied in neurons in a living brain. Massively Parallel Reporter Assays (MPRAs) are molecular genetic tools that enable functional screening of hundreds of predefined sequences in a single experiment. These assays have not yet been adapted to query specific cell types in vivo in a complex tissue like the mouse brain. Here, using a test-case 3′UTR MPRA library with genomic elements containing variants from ASD patients, we developed a method to achieve reproducible measurements of element effects in vivo in a cell type-specific manner, using excitatory cortical neurons and striatal medium spiny neurons as test cases. This new technique should enable robust, functional annotation of genetic elements in the cellular contexts most relevant to psychiatric disease.

[1]  J. Dougherty,et al.  Sex Significantly Impacts the Function of Major Depression–Linked Variants In Vivo , 2021, Biological Psychiatry.

[2]  P. Sullivan,et al.  Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum , 2022, Molecular Psychiatry.

[3]  J. Dougherty,et al.  Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays , 2021, bioRxiv.

[4]  A. Nord,et al.  Parallel functional testing identifies enhancers active in early postnatal mouse brain , 2021, bioRxiv.

[5]  David K. Yang,et al.  Genome-wide functional screen of 3′UTR variants uncovers causal variants for human disease and evolution , 2021, Cell.

[6]  J. Dougherty,et al.  Massively Parallel Reporter Assays: Defining Functional Psychiatric Genetic Variants Across Biological Contexts , 2020, Biological Psychiatry.

[7]  B. Cohen,et al.  CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3′ UTR Elements , 2020, Cell reports.

[8]  S. Ripke,et al.  Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia , 2020, medRxiv.

[9]  J. Piven,et al.  Common genetic risk variants identified in the SPARK cohort support DDHD2 as a candidate risk gene for autism , 2020, Translational Psychiatry.

[10]  Nir Yosef,et al.  lentiMPRA and MPRAflow for high-throughput functional characterization of gene regulatory elements , 2020, Nature Protocols.

[11]  Michael A. Kovacs,et al.  Massively parallel reporter assays of melanoma risk variants identify MX2 as a gene promoting melanoma , 2020, Nature Communications.

[12]  R. Mitra,et al.  A viral toolkit for recording transcription factor–DNA interactions in live mouse tissues , 2020, Proceedings of the National Academy of Sciences.

[13]  N. Zaitlen,et al.  Massively parallel analysis of human 3′ UTRs reveals that AU-rich element length and registration predict mRNA destabilization , 2020, bioRxiv.

[14]  Samantha A. Morris,et al.  Self-Reporting Transposons Enable Simultaneous Readout of Gene Expression and Transcription Factor Binding in Single Cells , 2019, Cell.

[15]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[16]  Matthew W. Mosconi,et al.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism , 2019, Cell.

[17]  Jay Shendure,et al.  Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution , 2019, Nature Communications.

[18]  K. Ansel,et al.  A massively parallel 3′ UTR reporter assay reveals relationships between nucleotide content, sequence conservation, and mRNA destabilization , 2019, Genome research.

[19]  Alicia R. Martin,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[20]  Ryan L. Collins,et al.  Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder , 2018, Science.

[21]  J. Corbo,et al.  A massively parallel reporter assay reveals context-dependent activity of homeodomain binding sites in vivo , 2018, Genome research.

[22]  Ryan L. Collins,et al.  An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder , 2018, Nature Genetics.

[23]  A. Schier,et al.  A Massively Parallel Reporter Assay of 3' UTR Sequences Identifies In Vivo Rules for mRNA Degradation. , 2017, Molecular cell.

[24]  C. Mayr.  Regulation by 3'-Untranslated Regions. , 2017, Annual review of genetics.

[25]  Len A. Pennacchio,et al.  Genomic Patterns of De Novo Mutation in Simplex Autism , 2017, Cell.

[26]  D. Carter,et al.  Novel Rbfox2 isoforms associated with alternative exon usage in rat cortex and suprachiasmatic nucleus , 2017, Scientific Reports.

[27]  S. Manti,et al.  Neuroinflammation in Autism Spectrum Disorders: Role of High Mobility Group Box 1 Protein , 2017, International journal of molecular and cellular medicine.

[28]  Eric S. Lander,et al.  Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay , 2016, Cell.

[29]  John G Flannery,et al.  Massively parallel cis-regulatory analysis in the mammalian central nervous system , 2016, Genome research.

[30]  T. Jensen,et al.  Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes , 2015, Nature Reviews Molecular Cell Biology.

[31]  Christopher S. Poultney,et al.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci , 2015, Neuron.

[32]  L. Pilaz,et al.  Post‐transcriptional regulation in corticogenesis: how RNA‐binding proteins help build the brain , 2015, Wiley interdisciplinary reviews. RNA.

[33]  M. Migliore,et al.  Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits , 2015, The Journal of Neuroscience.

[34]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[35]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[36]  Staci A. Sorensen,et al.  Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation , 2014, Front. Neural Circuits.

[37]  Morteza Mohammad Noori,et al.  Enhanced Regulatory Sequence Prediction Using Gapped k-mer Features , 2014, PLoS Comput. Biol..

[38]  Paul Greengard,et al.  Cell type–specific mRNA purification by translating ribosome affinity purification (TRAP) , 2014, Nature Protocols.

[39]  Wei Niu,et al.  Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.

[40]  S. Horvath,et al.  Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.

[41]  J. Shendure,et al.  Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model , 2013, Nature Genetics.

[42]  B. Cohen,et al.  Massively parallel in vivo enhancer assay reveals that highly local features determine the cis-regulatory function of ChIP-seq peaks , 2013, Proceedings of the National Academy of Sciences.

[43]  D. Geschwind,et al.  Sex differences in autism spectrum disorders. , 2013, Current opinion in neurology.

[44]  J. Dougherty,et al.  Identifying essential cell types and circuits in autism spectrum disorders. , 2013, International review of neurobiology.

[45]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[46]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[47]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[48]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[49]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[50]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[51]  Joseph B Hiatt,et al.  Massively parallel functional dissection of mammalian enhancers in vivo , 2012, Nature Biotechnology.

[52]  Timothy L. Bailey,et al.  Gene expression Advance Access publication May 4, 2011 DREME: motif discovery in transcription factor ChIP-seq data , 2011 .

[53]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[54]  Laurent Mottron,et al.  Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia , 2011, Human Genetics.

[55]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[56]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[57]  P. Greengard,et al.  A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types , 2008, Cell.

[58]  Robert F. Hevner,et al.  Transcription factors in glutamatergic neurogenesis: Conserved programs in neocortex, cerebellum, and adult hippocampus , 2006, Neuroscience Research.

[59]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.